Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
about
Systemic LPS causes chronic neuroinflammation and progressive neurodegenerationSelective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's diseaseThe role of early life environmental risk factors in Parkinson disease: what is the evidence?TSPO imaging in parkinsonian disordersInnate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist PerspectiveFriends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative DiseasesImplications of glial nitric oxide in neurodegenerative diseasesCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseasePotential benefits of therapeutic use of β2-adrenergic receptor agonists in neuroprotection and Parkinsonμs diseaseNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityMAO-B elevation in mouse brain astrocytes results in Parkinson's pathologyPesticides, microglial NOX2, and Parkinson's diseaseStriatal neuroinflammation promotes Parkinsonism in ratsThe expression and release of Hsp60 in 6-OHDA induced in vivo and in vitro models of Parkinson's diseasePhosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson diseaseCommon genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in miceNADPH oxidase as a therapeutic target in Alzheimer's disease.An alteration in the lateral geniculate nucleus of experimental glaucoma monkeys: in vivo positron emission tomography imaging of glial activation.Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease.Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.Heat shock protein 60: an endogenous inducer of dopaminergic cell death in Parkinson disease.Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's diseaseReactive microgliosis: extracellular micro-calpain and microglia-mediated dopaminergic neurotoxicity.Toxin-induced models of Parkinson's disease.Diminished brain resilience syndrome: A modern day neurological pathology of increased susceptibility to mild brain trauma, concussion, and downstream neurodegeneration.Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases.Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculatureResponse of aged parkinsonian monkeys to in vivo gene transfer of GDNFInflammatory regulation of ATP binding cassette efflux transporter expression and function in microgliaUse of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study.Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease.The endotoxin-induced neuroinflammation model of Parkinson's disease.HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration.Nonhuman primate models of Parkinson's disease.Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease.The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.Genome-wide association study confirms extant PD risk loci among the Dutch.IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
P2860
Q24614960-442D9A03-CC75-48E2-B3EC-1B8A4DD7E273Q24794457-E76EC318-DBC2-4E90-A9E7-23000A388F1FQ24815642-6E022DF6-5582-499B-B269-8386EB4D3644Q26747214-690FA1DF-E5A8-4F65-9884-90C54F06A17CQ26774441-6728D6C9-7B7D-44BD-BEB4-BA496B6C67B2Q26779933-C86AFC3F-0C95-49EF-BE00-6D97920501B4Q26782894-58449DEB-C408-4D26-A4B5-8B384D0E458DQ26849232-F014D182-033A-41E1-853F-594DBDE75BC4Q27012822-B3BE9AC8-3ECC-4317-B370-400C40E5C2CFQ27027973-81950C99-E007-4218-91DF-F90858726AA4Q27301926-8938E39D-999D-4A85-855A-EBFE116C1CEDQ28397585-0E37D386-07E9-492D-8EB8-DFE054CFCCA5Q28475466-8DA470C4-EBC9-4F98-9C49-44589103E6A6Q28581462-35F07786-95D2-408B-BCCD-634C3D46D2EEQ28742424-D0608C82-4E18-467A-9E26-B2FAB9111D99Q28943440-9C559A63-A77E-416C-93C6-9CE432FF51B7Q30523813-D8A2936E-2657-4B73-A7D4-5285E0B28E86Q30855129-EA9ED0EE-CC0F-4A8A-9A3E-371C085F43F7Q31047724-5E995088-5836-497E-920C-B9668EFB59E8Q33112256-E977F4B6-5F7E-42D6-BD17-3F8E571112B5Q33312931-57AE401C-F0B4-4A27-A685-876C22A508ACQ33602136-3B770169-761A-442E-B122-70EB97ABF951Q33811654-8BF90349-B535-435E-8F98-4E06E51C0D60Q33814799-E25C0DD3-7AE5-4F2C-82B4-2BE1054D608AQ33844749-48E02CB7-B3EB-4E1D-9D5A-F63D1BF38BA1Q33887236-76A4D73E-8591-4132-89A9-ECE10611F277Q33891870-EE6DC7FB-1D74-4FF3-8EA1-03D320443DA9Q34237258-79845C11-D35C-4A6A-B290-50521410903DQ34339833-9C8FDF7A-06C2-450A-AF6F-A84120EFACB9Q34401462-8939531C-EC77-4D38-A55F-5F168FB4FF6BQ34505182-A588E7AD-D53F-45BB-9D0E-B6FFC9A5515AQ34547466-FC0DA93F-DC00-4F49-B0DB-904942AE6528Q34557246-B5928AF4-C9BF-4421-90A5-610A36C03676Q34615988-5DAF6011-77A9-4875-88C2-3E39319836DCQ34665820-AE4D8B85-18DB-4FB9-9F88-E0F3AF10EEE4Q34784469-515BF422-90E4-4136-97B0-A6585A36ED05Q34983243-E6ED57B3-22E8-4D3E-AC7D-A6A0352BFF40Q35029070-3500B811-5AC3-4859-9BC2-B923A40795ACQ35030975-B5368EE0-9C80-42B3-9E94-F26CA7915267Q35064839-80604D0C-9934-4E8F-B5D4-DF7568A4A2B3
P2860
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Presence of reactive microglia ...... ahydropyridine administration.
@en
Presence of reactive microglia ...... ahydropyridine administration.
@nl
type
label
Presence of reactive microglia ...... ahydropyridine administration.
@en
Presence of reactive microglia ...... ahydropyridine administration.
@nl
prefLabel
Presence of reactive microglia ...... ahydropyridine administration.
@en
Presence of reactive microglia ...... ahydropyridine administration.
@nl
P2093
P356
P1433
P1476
Presence of reactive microglia ...... ahydropyridine administration.
@en
P2093
Andre Parent
Claudia Schwab
Doris Doudet
Patrick L McGeer
P304
P356
10.1002/ANA.10728
P577
2003-11-01T00:00:00Z